We are live on ! Find out more
OCA

OpenArc Corporate Advisory Portfolio holdings

AUM $8.41B
This Fund
S&P 500
This Quarter Est. Return
+16.96%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$8.41B
AUM Growth
+$1.42B
Cap. Flow
+$539M
Cap. Flow %
6.42%
Top 10 Hldgs %
33.46%
Holding
833
New
117
Increased
380
Reduced
255
Closed
44

Sector Composition

Rank Sector Weight
1 Technology 16.24%
2 Consumer Discretionary 5.63%
3 Healthcare 3.98%
4 Industrials 3.9%
5 Communication Services 3.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QLTA icon
826
iShares AAA-A Rated Corporate Bond ETF
QLTA
$1.21B
-6,637
Closed -$316K
RBLX icon
827
Roblox
RBLX
$27.5B
-3,588
Closed -$203K
RELX icon
828
RELX
RELX
$62.5B
-8,243
Closed -$273K
SEIC icon
829
SEI Investments
SEIC
$13.3B
-2,728
Closed -$214K
SPHY icon
830
State Street SPDR Portfolio High Yield Bond ETF
SPHY
$11.9B
-15,019
Closed -$350K
STKL
831
DELISTED
SunOpta
STKL
-206,296
Closed -$1.34M
TXT icon
832
Textron
TXT
$14.1B
-2,729
Closed -$239K
FLXR
833
TCW Flexible Income ETF
FLXR
$3.6B
-6,428
Closed -$252K

Similar funds

OpenArc Corporate Advisory's Q2 2026 Portfolio in Review

As of Q2 2026, OpenArc Corporate Advisory held 833 positions worth $8.41B, up 20% from $6.98B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

OpenArc Corporate Advisory deployed $539M of net new capital in Q2 2026, opening 117 new positions and adding to 380 existing holdings. Its largest new stake was iShares Russell 1000 ETF: 437,245 shares worth $179M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was iShares A.I. Innovation and Tech Active ETF, an estimated $119M trimmed.

  • OpenArc Corporate Advisory's largest Q2 2026 buy was iShares Russell 1000 ETF: 437,245 shares worth $179M.
  • OpenArc Corporate Advisory added most to Vanguard Russell 1000 Value ETF in Q2 2026, an estimated $55.3M increase.
  • OpenArc Corporate Advisory's biggest Q2 2026 reduction was iShares A.I. Innovation and Tech Active ETF, cutting an estimated $119M.
  • OpenArc Corporate Advisory fully exited Kiniksa Pharmaceuticals in Q2 2026, selling an estimated $2.33M.
  • OpenArc Corporate Advisory's ten largest holdings make up 33% of its $8.41B portfolio in Q2 2026.
  • OpenArc Corporate Advisory opened 117 new positions and closed 44 in Q2 2026.
  • OpenArc Corporate Advisory's portfolio value rose 20% quarter-over-quarter to $8.41B.

Based on OpenArc Corporate Advisory's 13F filing for Q2 2026, filed 5 Aug 2026.